A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT06348199 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06348199
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-12
- Primary completion
- 2026-03-10
- Enrollment
- 555
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.